Followers | 144 |
Posts | 27707 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Friday, January 20, 2017 7:53:24 AM
Jan. 20, 2017 7:16 AM ET|About: Pluristem Therapeutics... (PSTI)|By: Douglas W. House, SA News Editor
Pluristem Therapeutics (NASDAQ:PSTI) amends its underwriting agreement with H.C. Wainwright to increase its "bought deal" offering to $15M. Under the bought deal arrangement, Wainwright will purchase the entire offering of 12,244,898 Units at $1.225 per Unit. Each Unit consists of one share of common stock and 0.6 of a warrant to purchase one share of common at $1.40. Gross proceeds will be $15M.
Wainwright also has a 30-day option to buy up to an additional 1,836,735 Units. If exercised in full, gross proceeds will be $17.25M.
Net proceeds will fund R&D, clinical trial activities, investment in capital equipment, working capital and general corporate purposes.
Shares are off 17% premarket on increased volume.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM